FDA Issues Warning After Microdose Mushroom Chocolates Lead to Hospitalizations in 8 States

Health officials are once again cautioning against consuming a specific brand of microdosing mushroom-infused treats following reports of increased illnesses. The U.S. Food and Drug Administration (FDA) issued an initial warning on June 7 after several individuals were hospitalized with severe medical issues such as seizures, vomiting, and abnormal heart rate linked to Diamond Shruumz Microdosing Mushroom Chocolate Bars.

Originally investigating eight illnesses across four states, with six resulting in hospitalization, the FDA, alongside the Centers for Disease Control and Prevention, America’s Poison Centers, and local authorities, has now expanded its alert. Recent updates reveal a total of 12 reported cases and 10 hospitalizations spanning eight states, prompting an extension of the warning to encompass all Diamond-Shruumz products.

Here are the key points regarding the health officials’ warnings and the affected products:

Which mushroom candies are implicated?

All Diamond Shruumz-brand microdosing treats are included in the FDA warning, encompassing Chocolate Bars, Cones, and Gummies. This includes various quantities and flavors of Chocolate Bars and Gummies, as well as all flavors of Cones.

Which states are affected by Diamond Shruumz Microdosing Mushroom products? As of June 11, 2024, a total of 12 illnesses have been reported in eight states:

• Alabama (1 case)
• Arizona (4)
• Indiana (2)
• Kentucky (1)
• Missouri (1)
• Nevada (1)
• Pennsylvania (1)
• South Carolina (1)

Where are the mushroom candies sold?

These products are sold nationwide, both online and in-person, at various retail locations including smoke and vape shops, as well as outlets selling hemp-derived products like cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC). The FDA is actively investigating and does not have a comprehensive list of retailers selling the product.

What are the symptoms of the Diamond Shruumz candy illness?

According to the FDA, all 12 individuals affected sought medical attention, with 10 hospitalized as of June 11. Symptoms reported include seizures, central nervous system depression (such as loss of consciousness and confusion), agitation, abnormal heart rates, hypertension (high blood pressure), hypotension (low blood pressure), nausea, and vomiting.

FDA advisory: Dispose of affected mushroom candies immediately The FDA advises consumers to safely discard any Diamond Shruumz-brand products in their possession. These products should not be consumed, sold, or served. Parents and guardians are urged to discuss this advisory with children and teenagers, as the products are marketed as candy and may appeal to younger consumers.

Retailers are instructed not to sell or distribute any flavor of Diamond Shruumz-brand items and should secure any existing stock until further instructions are provided on proper disposal or return.

Individuals who experience illness after consuming Diamond Shruumz chocolates, gummies, or cones are encouraged to call the Poison Help Line at 1-800-222-1222 and seek immediate medical attention from a healthcare provider.